nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—Liothyronine—hypothyroidism	0.192	0.28	CbGbCtD
Tolvaptan—ABCB1—Levothyroxine—hypothyroidism	0.192	0.28	CbGbCtD
Tolvaptan—ABCB1—Liotrix—hypothyroidism	0.188	0.273	CbGbCtD
Tolvaptan—CYP3A4—Levothyroxine—hypothyroidism	0.115	0.168	CbGbCtD
Tolvaptan—AVPR2—urine—hypothyroidism	0.0435	0.47	CbGeAlD
Tolvaptan—AVPR1A—Vasopressin-like receptors—AVP—hypothyroidism	0.0189	0.143	CbGpPWpGaD
Tolvaptan—AVPR2—Vasopressin-like receptors—AVP—hypothyroidism	0.0188	0.142	CbGpPWpGaD
Tolvaptan—AVPR2—heart—hypothyroidism	0.0112	0.12	CbGeAlD
Tolvaptan—AVPR1A—adrenal gland—hypothyroidism	0.01	0.108	CbGeAlD
Tolvaptan—AVPR2—Arf6 trafficking events—CLTC—hypothyroidism	0.00796	0.0602	CbGpPWpGaD
Tolvaptan—AVPR1A—liver—hypothyroidism	0.00785	0.0847	CbGeAlD
Tolvaptan—Hypernatraemia—Liotrix—hypothyroidism	0.00765	0.0882	CcSEcCtD
Tolvaptan—CYP3A4—urine—hypothyroidism	0.00663	0.0715	CbGeAlD
Tolvaptan—AVPR2—Arf6 trafficking events—TSHR—hypothyroidism	0.00613	0.0463	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide GPCRs—TSHR—hypothyroidism	0.0043	0.0325	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide GPCRs—TSHR—hypothyroidism	0.00427	0.0322	CbGpPWpGaD
Tolvaptan—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00407	0.0469	CcSEcCtD
Tolvaptan—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00407	0.0469	CcSEcCtD
Tolvaptan—AVPR2—Vasopressin regulates renal water homeostasis via Aquaporins—AVP—hypothyroidism	0.00388	0.0293	CbGpPWpGaD
Tolvaptan—Dehydration—Dextrothyroxine—hypothyroidism	0.00369	0.0425	CcSEcCtD
Tolvaptan—Dehydration—Levothyroxine—hypothyroidism	0.00369	0.0425	CcSEcCtD
Tolvaptan—AVPR2—Aquaporin-mediated transport—AVP—hypothyroidism	0.00339	0.0256	CbGpPWpGaD
Tolvaptan—Body temperature increased—Liothyronine—hypothyroidism	0.00314	0.0362	CcSEcCtD
Tolvaptan—Renal impairment—Liotrix—hypothyroidism	0.00307	0.0354	CcSEcCtD
Tolvaptan—Hypoglycaemia—Liotrix—hypothyroidism	0.00299	0.0345	CcSEcCtD
Tolvaptan—Cerebrovascular accident—Liotrix—hypothyroidism	0.00298	0.0343	CcSEcCtD
Tolvaptan—AVPR2—G alpha (s) signalling events—TSHB—hypothyroidism	0.00282	0.0213	CbGpPWpGaD
Tolvaptan—AVPR2—G alpha (s) signalling events—TSHR—hypothyroidism	0.00282	0.0213	CbGpPWpGaD
Tolvaptan—Blood creatinine increased—Liotrix—hypothyroidism	0.00273	0.0315	CcSEcCtD
Tolvaptan—Dehydration—Liotrix—hypothyroidism	0.00271	0.0313	CcSEcCtD
Tolvaptan—AVPR1A—G alpha (q) signalling events—TRH—hypothyroidism	0.0023	0.0173	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—TRH—hypothyroidism	0.00227	0.0171	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—TRH—hypothyroidism	0.00225	0.017	CbGpPWpGaD
Tolvaptan—Renal failure—Liotrix—hypothyroidism	0.00221	0.0255	CcSEcCtD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.00205	0.0155	CbGpPWpGaD
Tolvaptan—Shock—Dextrothyroxine—hypothyroidism	0.00192	0.0221	CcSEcCtD
Tolvaptan—Shock—Levothyroxine—hypothyroidism	0.00192	0.0221	CcSEcCtD
Tolvaptan—Dysgeusia—Liotrix—hypothyroidism	0.00172	0.0198	CcSEcCtD
Tolvaptan—AVPR2—G alpha (s) signalling events—AVP—hypothyroidism	0.00166	0.0126	CbGpPWpGaD
Tolvaptan—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00161	0.0185	CcSEcCtD
Tolvaptan—Feeling abnormal—Levothyroxine—hypothyroidism	0.00161	0.0185	CcSEcCtD
Tolvaptan—Syncope—Liotrix—hypothyroidism	0.00158	0.0182	CcSEcCtD
Tolvaptan—Loss of consciousness—Liotrix—hypothyroidism	0.00154	0.0178	CcSEcCtD
Tolvaptan—Body temperature increased—Levothyroxine—hypothyroidism	0.00154	0.0178	CcSEcCtD
Tolvaptan—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00154	0.0178	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00152	0.0115	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.00151	0.0114	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00149	0.0112	CbGpPWpGaD
Tolvaptan—Anaphylactic shock—Liotrix—hypothyroidism	0.00143	0.0165	CcSEcCtD
Tolvaptan—Shock—Liotrix—hypothyroidism	0.00141	0.0163	CcSEcCtD
Tolvaptan—Asthenia—Levothyroxine—hypothyroidism	0.0014	0.0161	CcSEcCtD
Tolvaptan—Asthenia—Dextrothyroxine—hypothyroidism	0.0014	0.0161	CcSEcCtD
Tolvaptan—Pruritus—Levothyroxine—hypothyroidism	0.00138	0.0159	CcSEcCtD
Tolvaptan—Pruritus—Dextrothyroxine—hypothyroidism	0.00138	0.0159	CcSEcCtD
Tolvaptan—Anorexia—Liotrix—hypothyroidism	0.00137	0.0158	CcSEcCtD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00136	0.0102	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00136	0.0102	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.00135	0.0102	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.00135	0.0102	CbGpPWpGaD
Tolvaptan—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00133	0.0154	CcSEcCtD
Tolvaptan—Diarrhoea—Levothyroxine—hypothyroidism	0.00133	0.0154	CcSEcCtD
Tolvaptan—CYP3A4—blood—hypothyroidism	0.00127	0.0137	CbGeAlD
Tolvaptan—Decreased appetite—Liotrix—hypothyroidism	0.00125	0.0144	CcSEcCtD
Tolvaptan—ABCB1—adrenal cortex—hypothyroidism	0.00124	0.0134	CbGeAlD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00123	0.0093	CbGpPWpGaD
Tolvaptan—Constipation—Liotrix—hypothyroidism	0.00123	0.0141	CcSEcCtD
Tolvaptan—Headache—Levothyroxine—hypothyroidism	0.00122	0.0141	CcSEcCtD
Tolvaptan—Headache—Dextrothyroxine—hypothyroidism	0.00122	0.0141	CcSEcCtD
Tolvaptan—AVPR1A—G alpha (q) signalling events—AVP—hypothyroidism	0.00121	0.00911	CbGpPWpGaD
Tolvaptan—ABCB1—heart—hypothyroidism	0.0012	0.013	CbGeAlD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00119	0.009	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—AVP—hypothyroidism	0.00118	0.00893	CbGpPWpGaD
Tolvaptan—Feeling abnormal—Liotrix—hypothyroidism	0.00118	0.0136	CcSEcCtD
Tolvaptan—Nausea—Dextrothyroxine—hypothyroidism	0.00116	0.0134	CcSEcCtD
Tolvaptan—Nausea—Levothyroxine—hypothyroidism	0.00116	0.0134	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—TRH—hypothyroidism	0.00116	0.00875	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—TRH—hypothyroidism	0.00115	0.00869	CbGpPWpGaD
Tolvaptan—ABCB1—cardiovascular system—hypothyroidism	0.00113	0.0122	CbGeAlD
Tolvaptan—Body temperature increased—Liotrix—hypothyroidism	0.00113	0.0131	CcSEcCtD
Tolvaptan—AVPR2—G alpha (s) signalling events—POMC—hypothyroidism	0.00111	0.00835	CbGpPWpGaD
Tolvaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00108	0.00815	CbGpPWpGaD
Tolvaptan—Hypersensitivity—Liotrix—hypothyroidism	0.00106	0.0122	CcSEcCtD
Tolvaptan—AVPR1A—GPCR ligand binding—TSHR—hypothyroidism	0.00103	0.0078	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—TSHB—hypothyroidism	0.00103	0.0078	CbGpPWpGaD
Tolvaptan—ABCB1—gonad—hypothyroidism	0.00103	0.0111	CbGeAlD
Tolvaptan—Asthenia—Liotrix—hypothyroidism	0.00103	0.0119	CcSEcCtD
Tolvaptan—AVPR2—GPCR ligand binding—TSHR—hypothyroidism	0.00102	0.00774	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—TSHB—hypothyroidism	0.00102	0.00774	CbGpPWpGaD
Tolvaptan—Pruritus—Liotrix—hypothyroidism	0.00101	0.0117	CcSEcCtD
Tolvaptan—ABCB1—pituitary gland—hypothyroidism	0.001	0.0108	CbGeAlD
Tolvaptan—CYP3A4—liver—hypothyroidism	0.000991	0.0107	CbGeAlD
Tolvaptan—Diarrhoea—Liotrix—hypothyroidism	0.000981	0.0113	CcSEcCtD
Tolvaptan—Dizziness—Liotrix—hypothyroidism	0.000948	0.0109	CcSEcCtD
Tolvaptan—Headache—Liotrix—hypothyroidism	0.000899	0.0104	CcSEcCtD
Tolvaptan—ABCB1—adrenal gland—hypothyroidism	0.000897	0.00968	CbGeAlD
Tolvaptan—ABCB1—blood—hypothyroidism	0.000897	0.00968	CbGeAlD
Tolvaptan—ABCB1—thyroid gland—hypothyroidism	0.000866	0.00934	CbGeAlD
Tolvaptan—Nausea—Liotrix—hypothyroidism	0.000852	0.00982	CcSEcCtD
Tolvaptan—ABCB1—female gonad—hypothyroidism	0.000836	0.00902	CbGeAlD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000799	0.00604	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000793	0.00599	CbGpPWpGaD
Tolvaptan—AVPR1A—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000792	0.00598	CbGpPWpGaD
Tolvaptan—AVPR2—Peptide ligand-binding receptors—POMC—hypothyroidism	0.000786	0.00594	CbGpPWpGaD
Tolvaptan—ABCB1—testis—hypothyroidism	0.000742	0.008	CbGeAlD
Tolvaptan—ABCB1—liver—hypothyroidism	0.000701	0.00757	CbGeAlD
Tolvaptan—ABCB1—cerebellum—hypothyroidism	0.000685	0.00739	CbGeAlD
Tolvaptan—AVPR1A—GPCR downstream signaling—TRH—hypothyroidism	0.000655	0.00494	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—TRH—hypothyroidism	0.00065	0.00491	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—AVP—hypothyroidism	0.000608	0.0046	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—AVP—hypothyroidism	0.000604	0.00456	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TRH—hypothyroidism	0.000594	0.00449	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000594	0.00449	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TRH—hypothyroidism	0.00059	0.00446	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—TSHB—hypothyroidism	0.000583	0.00441	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—TSHR—hypothyroidism	0.000583	0.00441	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—TSHB—hypothyroidism	0.000579	0.00438	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—TSHR—hypothyroidism	0.000579	0.00438	CbGpPWpGaD
Tolvaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000531	0.00401	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TSHR—hypothyroidism	0.00053	0.004	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—TSHB—hypothyroidism	0.00053	0.004	CbGpPWpGaD
Tolvaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000527	0.00398	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TSHB—hypothyroidism	0.000526	0.00397	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—TSHR—hypothyroidism	0.000526	0.00397	CbGpPWpGaD
Tolvaptan—AVPR2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000468	0.00353	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CLTC—hypothyroidism	0.000406	0.00307	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR ligand binding—POMC—hypothyroidism	0.000404	0.00305	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CLTC—hypothyroidism	0.000403	0.00305	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR ligand binding—POMC—hypothyroidism	0.000401	0.00303	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—VAV3—hypothyroidism	0.000357	0.0027	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—VAV3—hypothyroidism	0.000354	0.00268	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TRH—hypothyroidism	0.000351	0.00265	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TRH—hypothyroidism	0.000349	0.00263	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AVP—hypothyroidism	0.000344	0.0026	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AVP—hypothyroidism	0.000341	0.00258	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—VAV3—hypothyroidism	0.000324	0.00245	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—VAV3—hypothyroidism	0.000322	0.00243	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TSHB—hypothyroidism	0.000313	0.00236	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TSHR—hypothyroidism	0.000313	0.00236	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AVP—hypothyroidism	0.000312	0.00236	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TSHB—hypothyroidism	0.000311	0.00235	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TSHR—hypothyroidism	0.000311	0.00235	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AVP—hypothyroidism	0.00031	0.00234	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000283	0.00214	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SH2B3—hypothyroidism	0.000279	0.00211	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SH2B3—hypothyroidism	0.000277	0.00209	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000235	0.00177	CbGpPWpGaD
Tolvaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000232	0.00175	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—POMC—hypothyroidism	0.000228	0.00173	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—POMC—hypothyroidism	0.000227	0.00171	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—POMC—hypothyroidism	0.000207	0.00157	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRL—hypothyroidism	0.000207	0.00156	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—POMC—hypothyroidism	0.000206	0.00156	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRL—hypothyroidism	0.000205	0.00155	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VAV3—hypothyroidism	0.000191	0.00145	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—IYD—hypothyroidism	0.000191	0.00144	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VAV3—hypothyroidism	0.00019	0.00144	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000188	0.00142	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AVP—hypothyroidism	0.000184	0.00139	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AVP—hypothyroidism	0.000183	0.00138	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ATP5O—hypothyroidism	0.000163	0.00123	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TPO—hypothyroidism	0.000153	0.00115	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000143	0.00108	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—POMC—hypothyroidism	0.000123	0.000926	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—POMC—hypothyroidism	0.000122	0.000919	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1—hypothyroidism	0.000118	0.000891	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—IYD—hypothyroidism	0.000118	0.00089	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1—hypothyroidism	0.000117	0.000884	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000113	0.000855	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ATP5O—hypothyroidism	0.0001	0.000757	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—POMC—hypothyroidism	9.99e-05	0.000754	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TPO—hypothyroidism	9.42e-05	0.000712	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	8.91e-05	0.000673	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TSHB—hypothyroidism	7.08e-05	0.000535	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3C2A—hypothyroidism	6.31e-05	0.000477	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC5A5—hypothyroidism	5.3e-05	0.0004	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TSHB—hypothyroidism	4.36e-05	0.000329	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	3.89e-05	0.000294	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC5A5—hypothyroidism	3.26e-05	0.000247	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—POMC—hypothyroidism	2.77e-05	0.000209	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—POMC—hypothyroidism	1.71e-05	0.000129	CbGpPWpGaD
